GRQ
PFE icon

Gardner Russo & Quinn’s Pfizer PFE Stock Holding History

Gardner Russo & Quinn’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,003
Closed -$69K – 148
2017
Q4 		$69K Buy
+2,003
New +$68.3K ﹤0.01% 150
2016
Q3 		– Sell
-20,975
Closed -$701K – 105
2016
Q2 		$701K Buy
+20,975
New +$669K 0.01% 73

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gardner Russo & Quinn's PFE Position: Q1 2018 in Review

Gardner Russo & Quinn sold out of Pfizer (PFE) in Q1 2018, closing a stake of 2,003 shares — an estimated $69K sold.

Gardner Russo & Quinn first reported a position in PFE in Q2 2016 and held it in 2 quarters. The position peaked at $701K in Q2 2016. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Gardner Russo & Quinn reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
  • Gardner Russo & Quinn sold 2,003 Pfizer shares in Q1 2018, an estimated $69K.
  • Gardner Russo & Quinn first reported a position in Pfizer in Q2 2016 and held it in 2 quarters.
  • Gardner Russo & Quinn's Pfizer position peaked at $701K in Q2 2016.
  • 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Gardner Russo & Quinn's 13F filing for Q1 2018, filed 11 May 2018.